MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/annonc/mds429

Медицинская библиотека · Annals of oncology : official journal of the European Society for Medical Oncology · 2012

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

Nooka A K, Nabhan C, Zhou X, Taylor M D, Byrtek M, Miller T P, Friedberg J W, Zelenetz A D, Link B K, Cerhan J R, Dillon H, Sinha R, Shenoy P J, Levy D, Dawson K, Hirata J H, Flowers C R

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Because follicular lymphoma (FL) patients have heterogeneous outcomes, the FL international prognostic index (FLIPI) was developed to risk-stratify patients and to predict survival. However, limited data exist regarding the role of FLIPI in the era of routine first-line rituximab (R) and R-chemotherapy regimens and in the setting of community oncology practices.

PATIENTS AND

METHODS

We evaluated the outcome data from the National LymphoCare Study (NLCS), a prospective, observational cohort study, which collects data on patients with FL in the United States (US) community practices.

RESULTS

Among 1068 male and 1124 female patients with FLIPI data, most were treated in US community practices (79%); 35% were FLIPI good risk, 30% intermediate risk, and 35% poor risk. FLIPI risk groups were significant predictors of overall survival (OS) and progression-free survival (PFS) for patients who undergo watchful waiting (WW), and those who receive non-R-containing regimens, R-alone, and R-chemotherapy combinations.

CONCLUSIONS

In the setting of contemporary practice with routine R use, stratifying patients into good, intermediate, and poor FLIPI risk groups predicts distinct outcomes in terms of OS and PFS. FLIPI remains an important prognostic index in the R era and should be used in clinical practices to support discussions about prognosis.

Для цитирования: Nooka A K, Nabhan C, Zhou X, Taylor M D, Byrtek M, Miller T P, Friedberg J W, Zelenetz A D, Link B K, Cerhan J R, Dillon H, Sinha R, Shenoy P J, Levy D, Dawson K, Hirata J H, Flowers C R. Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.. Annals of oncology : official journal of the European Society for Medical Oncology. 2012. DOI: 10.1093/annonc/mds429.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.